Sutureless Sorin Perceval Aortic Valve Implantation

The sutureless Perceval aortic valve (Sorin Group, Saluggia, Italy) is a device increasingly used in many European cardiac surgery centers. Since the first reports evaluating implantation feasibility and valve safety in humans in 2007, an increasing amount of data have become available, including premarketing clinical results and experience in particular conditions. Overall, excellent performances have been demonstrated in hemodynamic outcomes, safety, and versatility of use. However, several questions remain unanswered, especially regarding long-term durability, risk for endocarditis, and the need for postoperative pacemaker implantation. In this article, the most important studies published until now in the literature will be described, providing a state-of-the-art overview of current knowledge as well as future directions and indications for the use of the Perceval valve based on preliminary results of ongoing studies.